| News Updates! |
| The appearance of news releases and external hyperlinks does not constitute endorsement by PER of the news release; linked Web sites; or information, products, or positions contained therein. |
New test could track tumors in 'real time'
| $50M earmarked for cancer drugs
| Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
| UPDATE 1-EU body warns on anaemia drugs in cancer patients
|
Read More >> |
| Journal Watch Updates! |
| Decreased Survival With Maintenance Gefitinib Versus Placebo in Stage III NSCLC After Chemoradiotherapy and Consolidation | | May 28, 2008, 8:00 AM | J Clin Oncol | PubMed |
|
| Antiangiogenic Agents and Tumor Cavitation: Association With Squamous Histology but Not Hemoptysis in a Single-Institution Analysis | | May 8, 2008, 8:27 AM | J Thorac Oncol | PubMed |
|
| No Benefit With High-Dose Ifosfamide/Carboplatin/Etoposide in SCLC | | April 16, 2008, 8:34 AM | J Natl Cancer Inst | PubMed |
|
Read More >> |
|
|
